These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26594035)

  • 1. Mode of prostate cancer detection is associated with the psychological wellbeing of survivors: results from the PiCTure study.
    Drummond FJ; O'Leary E; Gavin A; Kinnear H; Sharp L
    Support Care Cancer; 2016 May; 24(5):2297-2307. PubMed ID: 26594035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-related symptoms predict psychological wellbeing among prostate cancer survivors: results from the PiCTure study.
    Sharp L; O'Leary E; Kinnear H; Gavin A; Drummond FJ
    Psychooncology; 2016 Mar; 25(3):282-91. PubMed ID: 26249170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing a population-based patient-reported outcomes study (PROMs) using national cancer registries across two jurisdictions: the Prostate Cancer Treatment, your experience (PiCTure) study.
    Drummond FJ; Kinnear H; Donnelly C; O'Leary E; O'Brien K; Burns RM; Gavin A; Sharp L
    BMJ Open; 2015 Apr; 5(4):e006851. PubMed ID: 25888474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study.
    Drummond FJ; Kinnear H; O'Leary E; Donnelly ; Gavin A; Sharp L
    J Cancer Surviv; 2015 Jun; 9(2):361-72. PubMed ID: 25563819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate specific antigen testing is associated with men's psychological and physical health and their healthcare utilisation in a nationally representative sample: a cross-sectional study.
    Flahavan EM; Drummond FJ; Bennett K; Barron TI; Sharp L
    BMC Fam Pract; 2014 Jun; 15():121. PubMed ID: 24938184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of stress, depression, and anxiety on PSA screening rates in a nationally representative sample.
    Kotwal AA; Schumm P; Mohile SG; Dale W
    Med Care; 2012 Dec; 50(12):1037-44. PubMed ID: 22955835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of investigation intensity and treatment differences on prostate cancer survivor's physical symptoms, psychological well-being and health-related quality of life: a two country cross-sectional study.
    Gavin AT; Donnelly D; Donnelly C; Drummond FJ; Morgan E; Gormley GJ; Sharp L
    BMJ Open; 2016 Dec; 6(12):e012952. PubMed ID: 27993906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer-related anxiety in long-term survivors after radical prostatectomy.
    Meissner VH; Herkommer K; Marten-Mittag B; Gschwend JE; Dinkel A
    J Cancer Surviv; 2017 Dec; 11(6):800-807. PubMed ID: 28528448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pain, fatigue and depression symptom cluster in survivors of prostate cancer.
    Baden M; Lu L; Drummond FJ; Gavin A; Sharp L
    Support Care Cancer; 2020 Oct; 28(10):4813-4824. PubMed ID: 31980895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological impact of serial prostate-specific antigen tests in Japanese men waiting for prostate biopsy.
    Kobayashi M; Nukui A; Kamai T
    Int J Clin Oncol; 2017 Feb; 22(1):174-180. PubMed ID: 27631094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptoms, unmet needs, psychological well-being and health status in survivors of prostate cancer: implications for redesigning follow-up.
    Watson E; Shinkins B; Frith E; Neal D; Hamdy F; Walter F; Weller D; Wilkinson C; Faithfull S; Wolstenholme J; Sooriakumaran P; Kastner C; Campbell C; Neal R; Butcher H; Matthews M; Perera R; Rose P
    BJU Int; 2016 Jun; 117(6B):E10-9. PubMed ID: 25818406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.
    Brindle LA; Oliver SE; Dedman D; Donovan JL; Neal DE; Hamdy FC; Lane JA; Peters TJ
    BJU Int; 2006 Oct; 98(4):777-82. PubMed ID: 16978272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flourishing or floundering? Prevalence and correlates of anxiety and depression among a population-based sample of adult cancer survivors 6months after diagnosis.
    Boyes AW; Girgis A; D'Este C; Zucca AC
    J Affect Disord; 2011 Dec; 135(1-3):184-92. PubMed ID: 21864913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life among symptomatic compared to PSA-detected prostate cancer survivors - results from a UK wide patient-reported outcomes study.
    Donnelly DW; Vis LC; Kearney T; Sharp L; Bennett D; Wilding S; Downing A; Wright P; Watson E; Wagland R; Cross WR; Mason MD; Siesling S; van Manen JG; Glaser AW; Gavin A
    BMC Cancer; 2019 Oct; 19(1):947. PubMed ID: 31615476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiety and depression among long-term survivors of cancer in Australia: results of a population-based survey.
    Boyes AW; Girgis A; Zucca AC; Lecathelinais C
    Med J Aust; 2009 Apr; 190(S7):S94-8. PubMed ID: 19351302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer.
    Sharp L; Carsin AE; Timmons A
    Psychooncology; 2013 Apr; 22(4):745-55. PubMed ID: 22411485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical value of prostate specific antigen screening in early detection of prostate cancer].
    Hua LX; Qiao D; Song NH; Feng NH; Yang J; Zhang JX; Chen JG; Zhang W; Sui YG; Wu HF
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):705-9. PubMed ID: 20021870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death.
    Hattangadi JA; Chen MH; D'Amico AV
    BJU Int; 2012 Dec; 110(11):1636-41. PubMed ID: 22757982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.
    Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H;
    Lancet Oncol; 2021 Sep; 22(9):1240-1249. PubMed ID: 34391509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PSA testing without clinical indication for prostate cancer in relation to socio-demographic and clinical characteristics in the Danish Diet, Cancer and Health Study.
    Karlsen RV; Larsen SB; Christensen J; Brasso K; Friis S; Tjønneland A; Dalton SO
    Acta Oncol; 2013 Nov; 52(8):1609-14. PubMed ID: 23978293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.